Technology & Business
Business Insider
Gizmodo
Kotaku
Lifehacker
Lifestyle
PEDESTRIAN.TV
POPSUGAR
Kin Community
image/svg+xml
bi-logo
bi-logo-refreshsuite-
Toggle navigation
Search Icon
A magnifying glass icon.
Tech
Money & Markets
Briefing
Ideas
Executive Life
Research
Makes Cents
Reviews
Globe Icon
An icon of the world globe.
Edition
AUS
Edition
AUSTRALIA
UNITED STATES
INTERNATIONAL
DEUTSCHLAND
ESPAÑA
FRANCE
INDIA
ITALY
JAPAN
MALAYSIA
NEDERLAND
NORDIC
POLSKA
SINGAPORE
SOUTH AFRICA
Search Icon
A magnifying glass icon.
Globe Icon
An icon of the world globe.
EDITION
AUSTRALIA
UNITED STATES
INTERNATIONAL
DEUTSCHLAND
ESPAÑA
FRANCE
INDIA
ITALY
JAPAN
MALAYSIA
NEDERLAND
NORDIC
POLSKA
SINGAPORE
SOUTH AFRICA
Tagged With Moderna Therapeutics
Meet Moderna's cofounder and chairman, whose coronavirus vaccine is now approved on both sides of the Atlantic. He loves basketball and Dolly Parton.
Juliana Kaplan
Dec 19, 2020, 3:19 AM
Travel stocks rally after Moderna's vaccine progress lifts hopes for near-term reopening
Ben Winck
Nov 17, 2020, 12:46 AM
Moderna shares soar 17% after early coronavirus vaccine trial produces antibodies in all patients
Ben Winck
Jul 15, 2020, 11:17 PM
A Harvard medical professor is now a billionaire after his early stake in Moderna soared 17,000%
Ben Winck
Apr 24, 2020, 1:52 AM
Dispensed: The pressures hitting the frontlines of the coronavirus response, all you need to know about a malaria pill Elon Musk and President Trump are touting, and more on coronavirus
Lydia Ramsey
Mar 21, 2020, 12:05 AM
Dispensed: How the US is confronting the novel coronavirus, Oscar and Clover's 2019 financial results, and the big business of direct-to-consumer healthcare
Lydia Ramsey
Mar 7, 2020, 3:45 AM
A small group of scientists, execs, and VCs are $277 million richer as their companies race to create a coronavirus vaccine. Here are 7 who have raked in huge sums.
Ben Winck
Feb 29, 2020, 12:24 AM
More than half of today's unicorn health startups haven't published any influential research — and some experts say that raises the risk of another Theranos
Erin Brodwin
Jan 31, 2019, 6:17 AM
Moderna tumbled in its Wall Street debut after the biggest IPO in biotech history
Lydia Ramsey, Emma Court
Dec 8, 2018, 3:48 AM
Moderna just priced the biggest IPO in biotech history, valuing the startup at $7.5 billion
Lydia Ramsey
Dec 7, 2018, 12:12 PM